curvefit.com. Guide to nonlinear regression.Try our software free for 30 days.StatMate leads you step by step through power and sample size calculations.InStat is a less cumbersome alternative to typical heavy-duty statistical programs. With InStat, even a statistical novice can analyze data in just a few minutes.Prism is a powerful combination of basic biostatistics, curve fitting and scientific graphing in one comprehensive program.GraphPad Software. Data analysis and biostatistics resources.


spa

Table of contents
Intro to regression
Nonlinear regression
Curve fitting with Prism
Interpreting the results
Comparing two curves
Distributions of best-fit values
Radioligand binding
Saturation binding
Competitive binding


s

Introduction
One kind of receptor
Shallow curves
Two kinds of receptors
Homologous
Ligand depletion
Kinetics of binding
Dose-response curves
Enzyme kinetics
Standard curves
More information
Search curvefit.com


curvefit.com was created by GraphPad Software, Inc. Send comments or questions to the author of these pages, Dr. Harvey Motulsky, president of GraphPad Software.

In April 2003, GraphPad released Prism 4 and published Fitting Models to Biological Data using Linear and Nonlinear Regression. This book includes all the information that comprises curvefit.com, and much more. You can read this book as a pdf file.

Title of page!

Competitive binding to two receptor types

Competitive binding with two sites with the same affinity for the radioligand

Included in the list of built-in equations of Prism is "Competitive binding (two sites)". This equation fits data for the fairly common situation where:

   There are two distinct classes of receptors. For example, a tissue could contain a mixture of b1 and b2 adrenergic receptors.
   The unlabeled ligand has distinct affinities for the two sites.
   The labeled ligand has equal affinity for both sites. (If you are not willing to make this assumption, see Competitive binding to two receptor types .
   Binding has reached equilibrium.
   A small fraction of both labeled and unlabeled ligand bind. This means that the concentration of labeled ligand that you added is very close to the free concentration in all tubes.
This equation has five variables: the top and bottom plateau binding, the fraction of the receptors of the first class, and the IC50 of competition of the unlabeled ligand for both classes of receptors. If you know the Kd of the labeled ligand and its concentration, you (or Prism) can convert the IC50 values to Ki values.

When you look at the competitive binding curve, you will only see a biphasic curve in unusual cases where the affinities are extremely different. More often you will see a shallow curve with the two components blurred together. For example, the graph below shows competition for two equally abundant sites with a ten fold (one log unit) difference in EC50. If you look carefully, you can see that the curve is shallow (it takes more than two log units to go from 90% to 10% competition), but you cannot see two distinct components.

Comparing one- and two-site models

Prism can simultaneously fit your data to two equations and compare the two fits. This feature is commonly used to compare a one-site competitive binding model and a two-site competitive binding model. Since the model has an extra parameter and thus the curve has an extra inflection point, the two-site model almost always fits the data better than the one site model. And a three-site model fits even better. Before accepting the more complicated models, you need to ask whether the improvement in goodness of fit is more than you'd expect by chance. Prism answers this question with an F test. The resulting P value answers this question: If the one site model were really correct, what is the chance that randomly chosen data points would fit to a two-site model this much better (or more so) than to a one-site model. See Comparing the fits of two models

Before looking at Prism's comparison of the two equations, you should look at both fits yourself. Sometimes the two-site fit gives results that are clearly nonsense. For example, disregard a two-site fit when:

   The two IC50 values are almost identical.
   One of the IC50 values is outside the range of your data.
   The variable FRACTION is close to 1.0 or to 0.0. In this case, virtually all the receptors have the same affinity, and the IC50 value for the other site will not be reliable.
   The variable FRACTION is negative or greater than 1.0.
   The best-fit values for BOTTOM or TOP are far from the range of Y values observed in your experiment.
If the results don't make sense, don't believe them. Only pay attention to the comparison of two fits when each of the fits makes sense.

Competitive binding to two receptor types with different affinities for the radioligand

The standard equation for competitive binding to two sites assumes that the labeled ligand has equal affinity for both sites. It is easy to derive an equation for situations where the labeled ligand binds differently to the two sites.

This is the standard equation for competitive binding to one site:

MathType Equation

Binding is the sum of specific and nonspecific binding. To create an equation for two sites, you simply need to create an equation with two specific binding components with different values for Bmax, Kd, and Ki.:

;Enter data with X=log[unlabeled] and Y=CPM
ColdnM=10^(X+9)
KI1nM = 10^(LogKI1+9)
KI2nM = 10^(LogKI2+9)
SITE1= HotnM*Bmax1/(HotnM + KD1*(1+coldnM/Ki1nM))
SITE2= HotnM*Bmax2/(HotnM + KD2*(1+coldnM/Ki2nM))
Y = SITE1 + SITE2 + NSCPM
Select this equation from the Advanced Radioligand Binding equation library.

Variable Units Comments
X log(Molar) Concentration of unlabeled drug.
Y cpm Total binding of radioligand.
HotnM nM Concentration of labeled ligand added to each tube. Set to a constant value.
KD1 nM Kd of the labeled ligand for the first site. Set to a constant value based on other experiments.
KD2 nM Kd of the labeled ligand for the second site. Set to a constant value .
logKI1 log(Molar) Affinity of the unlabeled drug for the first site. Initial value = 1.2*XMID
logKI2 log(Molar) Affinity of the unlabeled drug for the second site. Initial value = 0.8*XMID
Bmax1 Units of Y axis, usually cpm Initial value = 2*YMAX (This assumes that you've used a concentration of radioligand that binds to half of the receptors. You may wish to adjust this.)
Bmax2 Units of Y axis, usually cpm Initial value = 10*YMAX (This assumes that you've used a concentration of radioligand that binds to one tenth of the receptors.)
NSCPM Units of Y-axis, usually cpm. Nonspecific binding. Initial value = 1.0 * YMIN.

Notes:

   This equation does not account for ligand depletion. It assumes that the free concentration equals the added concentration.
   When using this equation to fit data, you will need to assign constant values to KD1 and KD2, the KD of the hot ligand for the two sites. You will need to obtain these values from other experiments. Perhaps you can isolate tissue with only one of the receptor types and measure KD in that preparation.

Homologous competitive binding curves


All contents copyright © 1999 by GraphPad Software, Inc. All rights reserved.